Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from... see more

TSXV:DM - Post Discussion

Datametrex AI Ltd > Pfizer vaccine needs to be kept at -65 Celcius
View:
Post by Resilience19 on Nov 09, 2020 1:14pm

Pfizer vaccine needs to be kept at -65 Celcius

Although it's not uncommon for vaccines to require a solid cold chain, it appears the Pfizer COVID-19 vaccine requires particularly sturdy storage constraints, in the sense that it needs to be kept at -65 Celcius.

I'm certainly not a medical logistics specialist but preliminary indications appearing online appear to indicate those constraints will limit the vaccine to distribution in the wealthiest of nations, where such environmental parameters need to be maintained.

We're likely to hear more in the coming days but just to say that it doesn't appear like we're quite out of the woods yet. So testign will remain a key element of C-19 management for some time yet.

For DM, this provides a window of opportunity to continue pushing forward its AI verticals and secure associated contracts, until such time the C-19 cash inflows dry out.
Comment by Pandora on Nov 09, 2020 1:55pm
Trudeau was briefly on the news this morning saying he was very pleased to hear the Pfizer news of their vaccine but he finished off by saying it will be many months, possibly longer, before we see significant change.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities